Cytarabine patient information

WebCytarabine is a potent bone marrow suppressant. Therapy should be started cautiously in patients with pre-existing drug-induced bone marrow suppression.Patients receiving this drug must be under close medical supervision and, during induction therapy, should have leukocyte and platelet counts performed daily. Bone marrow examinations should be … WebApr 6, 2024 · Vaccination with a live vaccine should be avoided in patients receiving cytarabine. Killed or inactivated vaccines may be administered; however, the response to such vaccines may be diminished. Excipient information. Cytarabine contains less than 1 mmol sodium (23 mg) in each vial, that is to say essentially 'sodium-free'.

Amsacrine/cytarabine/tioguanine SpringerLink

Cytarabine is approved to be used with other drugsto treat: 1. Acute non-lymphocytic leukemiain adults and children. Cytarabine is also approved to preventand treat: 1. Meningeal leukemia (leukemia that has … See more Definition from the NCI Drug Dictionary- Detailed scientific definition and other names for this drug. MedlinePlus Information on … See more Find Clinical Trials for Cytarabine- Check for trials from NCI's list of cancer clinical trials now accepting patients. See more WebCytarabine injection For the Patient: Cytarabine injection Other names: CYTOSAR® • Cytarabine (sye-TARE-a-been)is a drug that is used to treat many types of cancer. It is a clear liquid that is injected into a vein, muscle, or under the skin. • Tell your doctor if you have ever had an unusual or allergic reaction to cytarabine before taking cytarabine. dewalt battery dcb201 20v https://redgeckointernet.net

CYTARABINE Pfizer

WebApr 15, 2024 · The patient, who had AML, started receiving induction therapy with TAA regimen comprising of amsacrine 210 mg/m 2 on days 3−5, cytarabine 200 mg/m 2 over 24h on days 1−8 and tioguanine [thioguanine] 200 mg/m 2 on days 3−9. Medical history was significant for unspecified cardiac disease. Within first 30 days of therapy, the patient … WebNov 13, 2024 · Background: High dose cytarabine (HiDAC) consolidation in AML is conventionally given in the inpatient setting over approximately 6-7 days.Patients usually tolerate this treatment uneventfully, with occasional cytarabine-related fever or rash. As the demand for limited inpatient healthcare continues to escalate, there is an urgent need to … WebFind patient medical information for cytarabine injection on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. church lane playford

cytarabine injection - Pfizer Medical Information - US

Category:Cytarabine Leukemia and Lymphoma Society

Tags:Cytarabine patient information

Cytarabine patient information

Cytarabine Uses, Side Effects & Warnings - Drugs.com

WebThis drug may lower the ability of the bone marrow to make blood cells that the body needs. If blood cell counts get very low, this can lead to bleeding problems, infections, … WebCYTARABINE - INJECTION. (sye-TAIR-uh-bean) COMMON BRAND NAME (S): Cytosar-U, Tarabine PFS. WARNING: This medication may cause serious (rarely fatal) blood disorders (bone marrow suppression leading to anemia, low number of white blood cells and platelets). Liver problems may also occur.

Cytarabine patient information

Did you know?

WebApr 15, 2024 · The patient, who had AML, started receiving induction therapy with TAA regimen comprising of amsacrine 210 mg/m 2 on days 3−5, cytarabine 200 mg/m 2 over … WebLDAC: LDAC (Low dose cytarabine) has been evaluated in the setting of relapsed AML with results from a retrospective analysis of older patients with first relapse AML showing a CR rate of 17% and a median post-relapse survival of 5.6 months, which was not much better than for patients with best supportive care (3.2 months) [Citation 44].

WebDec 13, 2024 · DepoCyt® (cytarabine liposome injection) is supplied as a sterile, white to off-white suspension in 5 mL glass, single dose vials. Store refrigerated at 2° to 8°C (36° to 46°F). Protect from freezing and avoid aggressive agitation. Available in individual carton containing one ready to use vial. NDC 57665-331-01. WebCytarabine belongs to the category of chemotherapy called antimetabolites. Antimetabolites are very similar to normal substances within the cell. When the cells incorporate these …

WebCytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia (AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) is toxic but results in ... WebDESCRIPTION. Cytarabine Injection, an antineoplastic, is a sterile isotonic solution for intravenous and subcutaneous use, which contains no preservative and is available in 20 mg per mL (1,000 mg per 50 mL) Pharmacy Bulk Package. A Pharmacy Bulk Package is a container of a sterile preparation for parenteral use that contains many single doses.

WebDESCRIPTION. Cytarabine Injection, an antineoplastic, is a sterile solution of cytarabine for intravenous, intrathecal or subcutaneous administration and is available in 20 mg/mL …

WebPatient Education Sheets The following education sheets may be helpful. If you have not received any of these, please ask your health care worker for a copy. Cytarabine patient information sheet from Cancer Care Ontario Hematology Team (contact information for the hematology team) Fever, Infection and Side Effects while on Chemotherapy ... dewalt battery dcb207 not chargingWebMar 21, 2024 · These are not all the possible side effects of Cytarabine. For more information, ask your doctor or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at … church lane pirbrightWebTwo patients with childhood acute myelogenous leukemia who received intrathecal and intravenous cytarabine injection at conventional doses (in addition to a number of other concomitantly administered drugs) … church lane pinnerhttp://www.bccancer.bc.ca/drug-database-site/Drug%20Index/Cytarabineinjection_handout_1May07.pdf church lane postcodeWebApr 14, 2024 · Resistance to standard and novel therapies remains the main obstacle to cure in acute myeloid leukaemia (AML) and is often driven by metabolic adaptations which are therapeutically actionable. church lane pinhoeWebSep 26, 2011 · Flu-like symptoms from cytarabine. You may get a fever, skin rash, aches and pains or increased sweating. These symptoms are caused by the drug cytarabine. Symptoms usually happen 6 to 12 hours after your dose, and may last until 24 hours after your treatment has finished. church lane pleasleyWebCytarabine syndrome. Cytarabine syndrome sometimes happens about 6 to 12 hours after having this drug. It is a combination of symptoms including a high temperature, aching … church lane pocklington